These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 26614233

  • 21. Protocol-based image-guided salvage brachytherapy. Early results in patients with local failure of prostate cancer after radiation therapy.
    Lahmer G, Lotter M, Kreppner S, Fietkau R, Strnad V.
    Strahlenther Onkol; 2013 Aug; 189(8):668-74. PubMed ID: 23824103
    [Abstract] [Full Text] [Related]

  • 22. Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy.
    Susko M, Craciunescu O, Meltsner S, Yang Y, Steffey B, Cai J, Chino J.
    Int J Radiat Oncol Biol Phys; 2016 Apr 01; 94(5):1099-105. PubMed ID: 26883564
    [Abstract] [Full Text] [Related]

  • 23. Urethra-sparing, intraoperative, real-time planned, permanent-seed prostate brachytherapy: toxicity analysis.
    Zilli T, Taussky D, Donath D, Le HP, Larouche RX, Béliveau-Nadeau D, Hervieux Y, Delouya G.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e377-83. PubMed ID: 21514068
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Biochemical disease-free rate and toxicity for men treated with iodine-125 prostate brachytherapy with d(90) ≥180 Gy.
    Gómez-Iturriaga Piña A, Crook J, Borg J, Ma C.
    Int J Radiat Oncol Biol Phys; 2010 Oct 01; 78(2):422-7. PubMed ID: 20832665
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Dose constraint for minimizing grade 2 rectal bleeding following brachytherapy combined with external beam radiotherapy for localized prostate cancer: rectal dose-volume histogram analysis of 457 patients.
    Shiraishi Y, Yorozu A, Ohashi T, Toya K, Seki S, Yoshida K, Kaneda T, Saito S, Nishiyama T, Hanada T, Shigematsu N.
    Int J Radiat Oncol Biol Phys; 2011 Nov 01; 81(3):e127-33. PubMed ID: 21398047
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Comparison of acute and subacute genitourinary and gastrointestinal adverse events of radiotherapy for prostate cancer using intensity-modulated radiation therapy, three-dimensional conformal radiation therapy, permanent implant brachytherapy and high-dose-rate brachytherapy.
    Morimoto M, Yoshioka Y, Konishi K, Isohashi F, Takahashi Y, Ogata T, Koizumi M, Teshima T, Bijl HP, van der Schaaf A, Langendijk JA, Ogawa K.
    Tumori; 2014 Nov 01; 100(3):265-71. PubMed ID: 25076236
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Narrow safety range of intraoperative rectal irradiation exposure volume for avoiding bleeding after seed implant brachytherapy.
    Nakamura R, Kikuchi K, Tanji S, Yabuuchi T, Uwano I, Yamaguchi S, Ariga H, Fujioka T.
    Radiat Oncol; 2012 Jan 31; 7():15. PubMed ID: 22293400
    [Abstract] [Full Text] [Related]

  • 35. Late toxicity after single dose HDR prostate brachytherapy and EBRT for localized prostate cancer: Clinical and dosimetric predictors in a prospective cohort study.
    Büchser D, Casquero F, Espinosa JM, Perez F, Minguez P, Martinez-Indart L, Suarez F, Gonzalez A, Cacicedo J, San Miguel I, Maleta A, Gomez-Caamaño A, Bilbao P, Gomez-Iturriaga A.
    Radiother Oncol; 2019 Jun 31; 135():13-18. PubMed ID: 31015158
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Toxicities and dose-volume histogram parameters of MRI-based brachytherapy for cervical cancer.
    Kim Y, Kim YJ, Kim JY, Lim YK, Jeong C, Jeong J, Kim M, Lim MC, Seo SS, Park SY.
    Brachytherapy; 2017 Jun 31; 16(1):116-125. PubMed ID: 27876378
    [Abstract] [Full Text] [Related]

  • 38. Rectal spacing, prostate coverage, and periprocedural outcomes after hydrogel spacer injection during low-dose-rate brachytherapy implantation.
    Kahn J, Dahman B, McLaughlin C, Kapoor P, Kapoor R, Harris E, Sharma M, Schutzer M, Moghanaki D.
    Brachytherapy; 2020 Jun 31; 19(2):228-233. PubMed ID: 32085930
    [Abstract] [Full Text] [Related]

  • 39. A comparison of ICRU point doses and volumetric doses of organs at risk (OARs) in brachytherapy for cervical cancer.
    Vinod SK, Caldwell K, Lau A, Fowler AR.
    J Med Imaging Radiat Oncol; 2011 Jun 31; 55(3):304-10. PubMed ID: 21696566
    [Abstract] [Full Text] [Related]

  • 40. Predictive factors of long-term rectal toxicity following permanent iodine-125 prostate brachytherapy with or without supplemental external beam radiation therapy in 2216 patients.
    Tanaka T, Yorozu A, Sutani S, Yagi Y, Nishiyama T, Shiraishi Y, Ohashi T, Hanada T, Saito S, Toya K, Shigematsu N.
    Brachytherapy; 2018 Jun 31; 17(5):799-807. PubMed ID: 29936128
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.